New Analysis on Hypertension Treatment Presented as Late-Breaking Research at National Kidney Foundation Spring Clinical Meetings
May 17, 2024
May 17, 2024
LONG BEACH, California, May 17 (TNSres) -- The National Kidney Foundation issued the following news release:
A new analysis of a study comparing two commonly used medications, chlorthalidone (CTD) and hydrochlorothiazide (HCTZ), is set to be presented as a late-breaking presentation at the National Kidney Foundation 2024 Spring Clinical Meetings.
The study, titled "Treatment with Chlorthalidone vs Hydrochlorothiazide and Renal Outcomes: The Diuretic Comparison Proj . . .
A new analysis of a study comparing two commonly used medications, chlorthalidone (CTD) and hydrochlorothiazide (HCTZ), is set to be presented as a late-breaking presentation at the National Kidney Foundation 2024 Spring Clinical Meetings.
The study, titled "Treatment with Chlorthalidone vs Hydrochlorothiazide and Renal Outcomes: The Diuretic Comparison Proj . . .